Breaking News

Repligen Acquires Fluid Management Company Metenova

Gains magnetic mixing and drive train technologies that are widely used by global biopharmaceutical companies and CDMOs.

Repligen Corporation, a life sciences company focused on bioprocessing technology, entered into a definitive agreement to acquire privately held Metenova AB, a manufacturer of magnetic mixers for pharmaceutical and biotechnology use. Metenova is projected to generate revenues of $24 million to $25 million for fiscal year 2023, led by its magnetic mixing and drive train technologies that are widely used by global biopharmaceutical companies and contract development and manufacturing organizations (CDMOs).

The company recently entered the single-use mixing market with the launch of its MixOne platform, leveraging the success of its existing stainless steel (repeat-use) product line.

The company offers a broad range of products, including high power solutions for efficient media and buffer preparation, and low shear solutions for gentle mixing of sensitive proteins. Metenova’s aseptic mixing technologies are designed to minimize product damage and improve product yield and product consistency. The company’s solutions are applicable to a wide range of small molecule and large molecule therapeutics and vaccines, including monoclonal antibodies, recombinant proteins, and cell and gene therapies.

Tony Hunt, President, and CEO at Repligen said, “The addition of Metenova further strengthens our Fluid Management portfolio, with a product line that expands on the market success of our systems and fluid management assemblies and complements our recently acquired single-use bag business from FlexBiosys. We are excited to welcome the Metenova team to Repligen and we look forward to further developing and integrating their differentiated magnetic mixing technologies into our portfolio.”

Johan Westman, CEO at Metenova said, “We have made tremendous progress over the last ten years, building a market leading mixing portfolio. We are now at a stage in our development where we can benefit from more rapid expansion into the single-use market where many of our customers are scaling today. Repligen is the ideal partner for us to take this next step of growth and we look forward to working with our colleagues at Repligen to drive additional global demand for our single-use mixing products, while continuing to advance innovative single-use solutions for the industry.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters